InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,528.93
(
-2.12%
)
US TECH 100
18,420.40
(
-3.31%
)
Dow Jones
40,936.93
(
-1.51%
)
Brent Oil
73.29
(
-0.46%
)
Bitcoin
56,307.03
(
-1.94%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Investor100

Send PM Follow Ignore
Followers 505
Posts 6242
Boards Moderated 0
Alias Born 09/20/2006

Investor100

Re: $heff post# 24884

Tuesday, 03/23/2010 8:53:11 PM

Tuesday, March 23, 2010 8:53:11 PM

Post# of 97239
Piper Jaffray targets SLXP.

January 10,2010.

Piper Jaffray maintains an Overweight rating on Salix Pharmaceuticals (Nasdaq: SLXP), raises price target from $29 to $58.

http://www.streetinsider.com/Analyst+Comments/Piper+Jaffray+Names+Salix+Pharmaceuticals+(SLXP)+as+Top+Small+Cap+Pick+for+2010/5217873.html

GLTA

Investor 100
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up